1832 Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

1832 Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-450,000	Closed	-$218M	–	766
2025 Q3	$218M	Buy	450,000 +150,000	+50%	+$69.8M	0.17%	67
2025 Q2	$122M	Buy	+300,000	New	+$125M	0.09%	120

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management's TMO Position: Q1 2026 in Review

1832 Asset Management increased its Thermo Fisher Scientific (TMO) stake by 58% in Q1 2026, buying an estimated $394M and bringing the position to 1,969,618 shares worth $968M. The position accounts for 0.89% of the portfolio, ranked #23.

1832 Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

1832 Asset Management held 1,969,618 shares of Thermo Fisher Scientific worth $968M as of Q1 2026.
1832 Asset Management bought 725,093 Thermo Fisher Scientific shares in Q1 2026, an estimated $394M.
Thermo Fisher Scientific made up 0.89% of 1832 Asset Management's portfolio in Q1 2026, its #23 holding.
1832 Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.